Literature DB >> 24750176

A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma.

Miguel Martinez-Rodriguez1, Alec K Thompson, Carlos Monteagudo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24750176     DOI： 10.1111/his.12437

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  24 in total

Review 1.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

2.  Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.

Authors:  Francesca M Bosisio; James S Wilmott; Nathalie Volders; Marjorie Mercier; Jasper Wouters; Marguerite Stas; Willeke Am Blokx; Daniela Massi; John F Thompson; Richard A Scolyer; Nicolas van Baren; Joost J van den Oord
Journal:  Mod Pathol       Date:  2016-02-12       Impact factor: 7.842

Review 3.  Immunoplasticity in cutaneous melanoma: beyond pure morphology.

Authors:  Francesca Maria Bosisio; Joost J van den Oord
Journal:  Virchows Arch       Date:  2017-01-05       Impact factor: 4.064

Review 4.  B cells and antibody production in melanoma.

Authors:  Jessica Da Gama Duarte; Janique M Peyper; Jonathan M Blackburn
Journal:  Mamm Genome       Date:  2018-09-03       Impact factor: 2.957

Review 5.  A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance.

Authors:  Alexander C Huang; Roberta Zappasodi
Journal:  Nat Immunol       Date:  2022-03-03       Impact factor: 31.250

6.  Integrative immunogenomic analysis reveals transcriptional and immune-related differences in hepatocellular carcinoma patients with different disease-free survival.

Authors:  Xueling Yang; Guanglin Lei; Junxiao Wang; Zhenyu Wen; Zhenhu Ma; Yun Zhao; Hui Ren; Hui Xie
Journal:  Am J Cancer Res       Date:  2022-04-15       Impact factor: 5.942

7.  Tumor-associated B-cells induce tumor heterogeneity and therapy resistance.

Authors:  Rajasekharan Somasundaram; Gao Zhang; Mizuho Fukunaga-Kalabis; Michela Perego; Clemens Krepler; Xiaowei Xu; Christine Wagner; Denitsa Hristova; Jie Zhang; Tian Tian; Zhi Wei; Qin Liu; Kanika Garg; Johannes Griss; Rufus Hards; Margarita Maurer; Christine Hafner; Marius Mayerhöfer; Georgios Karanikas; Ahmad Jalili; Verena Bauer-Pohl; Felix Weihsengruber; Klemens Rappersberger; Josef Koller; Roland Lang; Courtney Hudgens; Guo Chen; Michael Tetzlaff; Lawrence Wu; Dennie Tompers Frederick; Richard A Scolyer; Georgina V Long; Manashree Damle; Courtney Ellingsworth; Leon Grinman; Harry Choi; Brian J Gavin; Margaret Dunagin; Arjun Raj; Nathalie Scholler; Laura Gross; Marilda Beqiri; Keiryn Bennett; Ian Watson; Helmut Schaider; Michael A Davies; Jennifer Wargo; Brian J Czerniecki; Lynn Schuchter; Dorothee Herlyn; Keith Flaherty; Meenhard Herlyn; Stephan N Wagner
Journal:  Nat Commun       Date:  2017-09-19       Impact factor: 14.919

8.  Spatiotemporal Analysis of B Cell- and Antibody Secreting Cell-Subsets in Human Melanoma Reveals Metastasis-, Tumor Stage-, and Age-Associated Dynamics.

Authors:  Minyi Chen; Franziska Werner; Christine Wagner; Martin Simon; Erika Richtig; Kirsten D Mertz; Johannes Griss; Stephan N Wagner
Journal:  Front Cell Dev Biol       Date:  2021-05-21

Review 9.  The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.

Authors:  Nicole J Flynn; Rajasekharan Somasundaram; Kimberly M Arnold; Jennifer Sims-Mourtada
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.864

10.  Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity.

Authors:  Jinming Yang; Chi Yan; Anna E Vilgelm; Sheau-Chiann Chen; Gregory D Ayers; Christopher A Johnson; Ann Richmond
Journal:  Cancer Immunol Res       Date:  2020-11-11       Impact factor: 12.020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.